Amphastar Pharmaceuticals, Inc. (AMPH) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $553.00M; Treasury Stock, ValueUSD $482.60M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-5.90M.
- 2026-03-31: Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $543.82M; Treasury Stock, ValueUSD $438.00M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-5.74M.
- 2025-12-31: Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $535.38M; Treasury Stock, ValueUSD $408.15M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-5.31M.
- 2025-09-30: Common Stock, Value, IssuedUSD $6.00K; Additional Paid in CapitalUSD $527.22M; Treasury Stock, ValueUSD $387.65M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-5.27M.
Amphastar Pharmaceuticals, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Preferred Stock, Value, Issued USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | Treasury Stock, Shares, Acquired shares | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD | Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.00K | $553.00M | $482.60M | $-5.90M | $703.65M | $768.16M | 3 month · $44.70M | 3 month · $7.09M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $6.00K | $543.82M | $438.00M | $-5.74M | $673.30M | $773.39M | 3 month · $30.00M | 3 month · $9.27M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $6.00K | $535.38M | $408.15M | $-5.31M | $666.88M | $788.80M | 12 month · $75.59M | 12 month · $27.28M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $6.00K | $527.22M | $387.65M | $-5.27M | $642.45M | $776.75M | 3 month · $4.85M | 3 month · $6.30M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $6.00K | $520.58M | $382.85M | $-5.36M | $625.10M | $757.48M | 3 month · $39.00M | 3 month · $6.38M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $6.00K | $509.11M | $343.93M | $-7.97M | $594.07M | $751.28M | 3 month · $11.22M | 3 month · $8.39M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $6.00K | $505.40M | $332.71M | $-9.18M | $568.79M | $732.30M | 12 month · $85.46M | 12 month · $24.37M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $6.00K | $496.43M | $290.76M | $-8.82M | $530.82M | $727.68M | 3 month · $34.96M | 3 month · $5.60M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $6.00K | $487.57M | $255.80M | $-8.83M | $490.39M | $713.35M | 3 month · $8.50M | 3 month · $5.78M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $6.00K | $476.07M | $247.40M | $-8.77M | $452.44M | $672.36M | (m) | 3 month · $7.36M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $6.00K | $486.06M | $247.43M | $-8.48M | $409.27M | $639.42M | 12 month · $58.14M | 12 month · $20.24M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $6.00K | $477.88M | $247.44M | $-8.41M | $373.10M | $595.14M | 3 month · $50.00M | 3 month · $4.64M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $6.00K | $471.11M | $197.44M | $-8.32M | $323.88M | $589.24M | 3 month · $129.00K | 3 month · $4.87M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $6.00K | $456.62M | $197.54M | $-8.27M | $297.75M | $548.58M | 3 month · $8.02M | 3 month · $6.11M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $6.00K | $455.08M | $189.52M | $-8.62M | $271.72M | $528.66M | 12 month · $39.91M | 12 month · $17.86M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $6.00K | $448.74M | $171.46M | $-9.93M | $237.81M | $505.17M | 3 month · $14.49M | 3 month · $4.30M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $6.00K | $443.04M | $156.97M | $-8.71M | $221.94M | $499.31M | 3 month · $6.12M | 3 month · $4.24M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $6.00K | $433.45M | $151.28M | $-7.25M | $204.59M | $479.52M | 3 month · $1.23M | 3 month · $5.02M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $6.00K | $422.42M | $150.48M | $-6.76M | $180.34M | $445.52M | 12 month · $28.87M | 12 month · $17.84M | (m) | $445.52M | (m) | (m) | (m) | (m) |
| 2021-09-30 | $6.00K | $412.92M | $137.05M | $-6.28M | $160.58M | $430.18M | 3 month · $6.09M | 3 month · $3.92M | (m) | $430.18M | (m) | (m) | (m) | (m) |
| 2021-06-30 | $6.00K | $427.30M | $130.96M | $-4.93M | $130.58M | $467.22M | 3 month · $5.56M | 3 month · $5.24M | (m) | $421.99M | (m) | (m) | (m) | (m) |
| 2021-03-31 | $6.00K | $413.93M | $125.55M | $-5.64M | $122.81M | $450.96M | 3 month · $3.78M | 3 month · $4.83M | (m) | $405.56M | (m) | (m) | (m) | (m) |
| 2020-12-31 | $5.00K | $410.06M | $121.81M | $-3.72M | $117.77M | $448.72M | 12 month · $24.43M | 12 month · $20.50M | (m) | $402.31M | (m) | (m) | (m) | (m) |
| 2020-09-30 | $5.00K | $404.08M | $118.42M | $-4.48M | $124.05M | $450.96M | 3 month · $4.33M | 3 month · $4.37M | (m) | $450.96M | (m) | (m) | (m) | (m) |
| 2020-06-30 | $5.00K | $396.84M | $114.12M | $-5.17M | $120.13M | $442.44M | 3 month · $5.76M | 3 month · $6.51M | (m) | $397.68M | (m) | (m) | (m) | (m) |
| 2020-03-31 | $5.00K | $371.14M | $108.49M | $-5.46M | $120.32M | $423.37M | 3 month · $10.95M | 3 month · $5.28M | (m) | $377.51M | (m) | (m) | (m) | (m) |
| 2019-12-31 | $5.00K | $367.31M | $97.63M | $-4.69M | $116.37M | $427.53M | 12 month · $22.29M | 12 month · $17.30M | (m) | $381.37M | (m) | (m) | (m) | (m) |
| 2019-09-30 | $5.00K | $361.70M | $83.85M | $-5.85M | $117.40M | $433.65M | 3 month · $4.43M 9 month · $8.51M | 3 month · $4.29M 9 month · $13.00M | (m) | $389.40M | (m) | (m) | (m) | (m) |
| 2019-06-30 | $5.00K | $355.44M | $79.46M | $-4.22M | $116.09M | $432.29M | 3 month · $1.07M 6 month · $4.09M | 3 month · $4.03M 6 month · $8.71M | (m) | $387.85M | (m) | (m) | (m) | (m) |
| 2019-03-31 | $5.00K | $349.20M | $78.39M | $-4.13M | $68.30M | $380.27M | 3 month · $3.02M | 3 month · $4.67M | (m) | $334.99M | (m) | (m) | (m) | (m) |
| 2018-12-31 | $5.00K | $344.43M | $75.48M | $-4.01M | $67.48M | $364.36M | 12 month · $25.05M | 12 month · $16.68M | (m) | $332.44M | (m) | (m) | (m) | (m) |
| 2018-09-30 | $5.00K | $330.26M | $72.90M | $-3.58M | $65.62M | $341.27M | 3 month · $7.59M 9 month · $22.44M | 3 month · $3.91M 9 month · $12.77M | (m) | $319.42M | (m) | (m) | (m) | (m) |
| 2018-06-30 | $5.00K | $322.36M | $65.45M | $-3.17M | $66.78M | $316.98M | 3 month · $7.23M 6 month · $14.85M | 3 month · $4.20M 6 month · $8.86M | (m) | $320.53M | (m) | (m) | (m) | (m) |
| 2018-03-31 | $5.00K | $316.67M | $58.23M | $-910.00K | $69.57M | $323.62M | 3 month · $7.62M | 3 month · $4.67M | (m) | $327.10M | (m) | (m) | (m) | (m) |
| 2017-12-31 | $5.00K | $313.89M | $50.70M | $-2.10M | $72.64M | $333.74M | 12 month · $30.75M | 12 month · $17.09M | (m) | $333.74M | (m) | (m) | (m) | (m) |
| 2017-09-30 | $5.00K | $303.21M | $44.73M | $-2.60M | $74.77M | $327.74M | 3 month · $7.59M 9 month · $24.77M | 3 month · $4.16M 9 month · $12.90M | (m) | $330.65M | (m) | (m) | (m) | (m) |
| 2017-06-30 | $5.00K | $299.11M | $37.17M | $-3.22M | $74.59M | $330.48M | 6 month · $17.18M | 6 month · $8.75M | (m) | $333.31M | (m) | (m) | (m) | (m) |
| 2017-03-31 | $5.00K | $285.36M | $28.19M | $-4.23M | $72.62M | (m) | 3 month · $8.20M | (m) | (m) | $325.56M | (m) | (m) | (m) | (m) |
| 2016-12-31 | $5.00K | $283.12M | $20.03M | $-4.70M | $70.86M | $326.52M | 12 month · $9.91M | 12 month · $15.12M | (m) | $329.25M | (m) | (m) | (m) | 12 month · $421.00K |
| 2016-09-30 | $5.00K | $276.54M | $19.11M | $-2.58M | $73.60M | (m) | 9 month · $8.99M | (m) | (m) | $328.45M | (m) | (m) | (m) | (m) |
| 2016-06-30 | $5.00K | $258.79M | $18.34M | $-2.69M | $69.71M | (m) | 6 month · $8.19M | (m) | (m) | $307.46M | (m) | (m) | (m) | (m) |
| 2016-03-31 | $5.00K | $250.68M | $14.88M | $-2.04M | $62.81M | (m) | 3 month · $4.72M | (m) | (m) | $296.58M | (m) | (m) | (m) | (m) |
| 2015-12-31 | $5.00K | $247.83M | $10.17M | $-2.48M | $60.32M | $293.49M | 12 month · $9.87M | 12 month · $12.81M | (m) | $295.51M | (m) | (m) | 12 month · $107.00K | (m) |
| 2015-09-30 | $5.00K | $240.75M | $5.99M | $-3.76M | $52.79M | (m) | 9 month · $5.69M | (m) | (m) | $283.79M | (m) | (m) | (m) | (m) |
| 2015-06-30 | $5.00K | $236.66M | $3.06M | $-4.13M | $55.80M | (m) | 3 month · $1.20M 6 month · $2.71M | (m) | $0.00 | $285.26M | (m) | 3 month · 79.40K 6 month · 195.70K | (m) | (m) |
| 2015-03-31 | $4.00K | $223.31M | $1.83M | $-4.65M | $62.45M | (m) | 3 month · $1.49M | (m) | $0.00 | $279.28M | (m) | 3 month · 116.30K | (m) | (m) |
| 2014-12-31 | $4.00K | $220.75M | $345.00K | $-1.65M | $63.11M | (m) | 12 month · $345.00K | 12 month · $9.28M | $0.00 | $281.86M | 12 month · $3.36M | 12 month · 29.40K | 12 month · $1.11M | 12 month · $1.11M |
| 2014-09-30 | $4.00K | $219.29M | (m) | $-1.80M | $65.63M | (m) | (m) | (m) | $0.00 | $283.12M | (m) | (m) | (m) | (m) |
| 2014-06-30 | $4.00K | $217.00M | (m) | $-268.00K | $71.01M | (m) | (m) | (m) | $0.00 | $287.74M | (m) | (m) | (m) | (m) |
| 2013-12-31 | $4.00K | $177.73M | (m) | (m) | $73.81M | (m) | (m) | (m) | $0.00 | $251.54M | (m) | (m) | 12 month · $647.00K | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $233.44M | (m) | (m) | 12 month · $120.00K | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $208.52M | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |